Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
出版年份 2011 全文链接
标题
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 105, Issue 6, Pages 796-806
出版商
Springer Nature
发表日期
2011-08-17
DOI
10.1038/bjc.2011.321
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
- (2012) Christian Widakowich et al. Anti-Cancer Agents in Medicinal Chemistry
- Abstract 100: Preclinical and clinical studies data consolidation and federation using an integrative data analysis system: SIMUSITETM
- (2011) Meena I. Vora CANCER RESEARCH
- A Message from the New Editor-in-Chief
- (2010) G. C. Prendergast CANCER RESEARCH
- Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
- (2010) C. L. Efferson et al. CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts
- (2010) Mothaffar F. Rimawi et al. CLINICAL CANCER RESEARCH
- The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches
- (2010) Lara Lacerda et al. DRUG RESISTANCE UPDATES
- Chronic DLL4 blockade induces vascular neoplasms
- (2010) Minhong Yan et al. NATURE
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
- Aromatase resistance mechanisms in model systems in vivo
- (2009) Angela Brodie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
- (2009) Bella Kaufman et al. LANCET ONCOLOGY
- Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
- (2008) Takashi Mine et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Role for Notch Signaling in Stromal Survival and Differentiation during Prostate Development
- (2008) Brigid Orr et al. ENDOCRINOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation